Half-year summary of the liquidity contract_December 2012


Press release

Avignon, January 7th, 2013


Pursuant to the liquidity contract granted to NATIXIS regarding NATUREX shares, the following elements were in the liquidity account as of December 31st, 2012:



2,357 NATUREX shares
601,658.69 euros

The following elements appeared on the liquidity account as of June 30th, 2012:



12,028 NATUREX shares
106,273.45 euros

For information, the following elements appeared on the liquidity account at the time of the implementation of the liquidity contract:



923 NATUREX shares
277,801.85 euros

Download our press releases and other publications on www.naturex.com




Naturex has been listed on NYSE Euronext Paris, Compartment B (Mid Caps), since October 1996.






 
Total number of shares comprising the share capital: 7,728,539

ISIN FR0000054694

 

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

 

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY




About Naturex

Naturex is the global leader in speciality plant-based natural ingredients.


The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).


Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.





> Contacts
 


 

Thierry Lambert

Chairman and Chief Executive Officer

Tel: +33 (0)4 90 23 96 89

t.lambert@naturex.com

 
Thierry Bertrand Lambert

Chief Financial Officer

Tel: +33 (0)4 90 23 96 89

t.blambert@naturex.com




Carole Alexandre

Investor Relations

Tel: +33 (0)4 90 23 78 28

c.alexandre@naturex.com


Anne Catherine Bonjour

Actus Finance Press Relations

Tel: +33 (0)1 53 67 36 93

acbonjour@actus.fr

Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité
Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-30551-2013.01.07-summary-of-liquidity-contract-december-2012.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


<br/><p>Quelle: <a href="http://www.actusnews.com/" target="_blank" rel="nofollow">Actusnews</a></p>